Medical University of South Carolina

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1955-01-01

Employees: 10K

Market Cap: -

Website: https://www.muschealth.com

Clinical Trials

Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus

Phase 1

Completed

Conditions: System; Lupus Erythematosus

Interventions: Drug: Low Dose Mesenchymal Stem Cells (MSCs)

First Posted Date: 2017-05-31

Last Posted Date: 2019-05-02

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 6

Registration Number: NCT03171194

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Tension Tamer Randomized Control Trial

Not Applicable

Completed

Conditions: Pre-hypertension

Interventions: Behavioral: Tension Tamer (TT)
Behavioral: Lifestyle education program (SPCTL)

First Posted Date: 2017-05-30

Last Posted Date: 2020-01-14

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 80

Registration Number: NCT03168789

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial).

Completed

Conditions: Hepatic Carcinoma
Transarterial Embolization
Chemoembolizaton

First Posted Date: 2017-05-22

Last Posted Date: 2017-05-22

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 55

Registration Number: NCT03163186

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Safety and Efficacy of a Novel Facemask for Positive Pressure Ventilation

Not Applicable

Completed

Conditions: Anesthesia Induction Ventilation

Interventions: Device: Waters Mask
Other: Standard Mask

First Posted Date: 2017-05-18

Last Posted Date: 2017-05-18

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 152

Registration Number: NCT03158207

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

A "Window Trial" on Boswellia for Breast Cancer Primary Tumors

Phase 1

Completed

Conditions: Breast Cancer

Interventions: Drug: Boswellia

First Posted Date: 2017-05-11

Last Posted Date: 2024-04-30

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 46

Registration Number: NCT03149081

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Investigator-Initiated Trial of Combined Ipilimumab, Nivolumab and Stereotactic Radiation in Patients With Metastatic Clear-Cell RCC (ccRCC) Who Have Failed Treatment With Single-Agent Nivolumab

Phase 2

Withdrawn

Conditions: Clear Cell Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma

Interventions: Drug: Nivolumab
Drug: Ipilimumab
Radiation: Steriotactic radiation therapy

First Posted Date: 2017-05-11

Last Posted Date: 2018-06-18

Lead Sponsor: Medical University of South Carolina

Registration Number: NCT03149159

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

CBSM Intervention Via mHealth to Ameliorate HIV-related Fatigue

Not Applicable

Completed

Conditions: Stress Disorder
HIV
Human Immunodeficiency Virus
Fatigue

Interventions: Behavioral: CBSM-SMI
Behavioral: CBSM-SMI control

First Posted Date: 2017-05-11

Last Posted Date: 2018-07-18

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 30

Registration Number: NCT03149094

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer

Terminated

Conditions: PET CT

First Posted Date: 2017-05-09

Last Posted Date: 2018-06-21

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 25

Registration Number: NCT03146117

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

LYmphangiogenesis FacTors in Heart Failure States

Completed

Conditions: Heart Failure With Reduced Ejection Fraction
Heart Failure With Normal Ejection Fraction
Heart Failure

First Posted Date: 2017-05-05

Last Posted Date: 2023-07-14

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 100

Registration Number: NCT03141567

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
🇺🇸
Ralph H. Johnson VAMC, Charleston, South Carolina, United States

LAM Pilot Study With Imatinib Mesylate

Phase 1

Completed

Conditions: Lymphangioleiomyomatosis

Interventions: Drug: Imatinib Mesylate 400Mg Capsule
Drug: Placebo - Capsule

First Posted Date: 2017-04-27

Last Posted Date: 2020-06-16

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 18

Registration Number: NCT03131999

Locations: 🇺🇸
Columbia University, New York, New York, United States
🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy